USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Samsung Medison Co., Ltd.

USPTO PatentsView assignee record - 439 granted patents across 56 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

439
Total patents granted
56
CPC technology areas
15.8
Avg claims per patent
-26%
5-year filing velocity

The verdict

Samsung holds 439 US patents across 56 technology areas, rank #1,000 of 50,000 tracked assignees.

#1,000
of 50,000 US assignees by volume
Top 4%
by Innovation Score (59.9/100)
15.8
avg claims per patent
-26%
filing velocity, last 5 yrs

Portfolio overview

Samsung Medison Co., Ltd. has been granted 439 US utility patents between 2015 and 2025, placing Samsung Medison Co., Ltd. at rank #1,000 across all assignees tracked by PlainPatent. This portfolio spans 56 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.8 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Samsung Medison Co., Ltd. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Samsung sits between Siemens Industry, Inc. (442 patents, rank #996) and Advantest Corporation (437 patents, rank #1,004) - the closest US assignees by grant volume. The composite Innovation Score of 59.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 186 grants, compared with 253 in the 2015–2019 window, a -26% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Samsung Medison Co., Ltd.'s 15.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 56 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Samsung Medison Co., Ltd. against peers pursuing similar technology classes.

Who files at Samsung's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Samsung holds 439 patents at rank #1,000, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Samsung

By rank, the assignees closest to #1,000 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Samsung's primary technology class.

Samsung's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

60 Top 4% higher than 96% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). Below this entry. 60–70: 1,537 US assignees (3%). This entry sits in this band. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

020406080 20152016201720182019202020212022202320242025 13
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Samsung Medison Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 50 11.4%
2016 50 11.4%
2017 46 10.5%
2018 43 9.8%
2019 64 14.6%
2020 45 10.3%
2021 34 7.7%
2022 39 8.9%
2023 36 8.2%
2024 19 4.3%
2025 13 3.0%

Which technologies does Samsung Medison Co., Ltd. patent most?

Top 15 of 56 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#1,000

Across all tracked assignees

Innovation Score

59.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Samsung Medison Co., Ltd. hold?
Samsung Medison Co., Ltd. holds 439 US granted patents filed between 2015 and 2025, spanning 56 technology areas.
What is Samsung Medison Co., Ltd.'s Innovation Score?
Samsung Medison Co., Ltd. has an Innovation Score of 59.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Samsung Medison Co., Ltd. focus on?
Samsung Medison Co., Ltd.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 387 patents. The company has filed patents in 56 CPC subclasses total.
Is Samsung Medison Co., Ltd.'s patent filing rate increasing or decreasing?
Samsung Medison Co., Ltd.'s recent filing velocity is -26% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Samsung Medison Co., Ltd.'s patents?
Samsung Medison Co., Ltd.'s patents average 15.8 claims each. This falls within the standard range, providing solid legal coverage.
How is the Samsung Medison Co., Ltd. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Samsung's 439 grants land it in the top 4% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Samsung ranks #1,000 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.